2018 Sarcoma Symposium: Emerging Therapies and Diagnostic Strategies for Patients with High Risk and Relapsed Bone and Soft Tissue Sarcoma
Date: September 7, 2018
Location: The Research Institute at Nationwide Children’s Hospital, Columbus, OH
Registration is free!
Registration: Click here to register to attend
- Nationwide Children’s Hospital Division of Hematology/Oncology/BMT
- Nationwide Children’s Hospital Education Institute
- Precision Medicine/Genomics
- Canine Comparative Oncology
- Radiation Oncology
- Clinical Trials/New Therapeutic Developments
Abha Gupta, MD, The Hospital for Sick Children
Katherine A. Janeway, MD, Dana-Farber Cancer Institute
Stephen L. Lessnick, MD, PhD, Nationwide Children’s Hospital Center for Childhood Cancer and Blood Diseases
Lars M. Wagner, MD, University of Kentucky HealthCare
Click here to view the full conference agenda.
The symposium is designed to address novel and emerging treatments of patients with primary metastatic and relapsed bone and soft tissue sarcoma. Despite intensive therapies and incorporation of novel agents, the therapeutic plateau has not been overcome. The aim of this symposium is to review known strategies of care for this patient population with aggressive disease and highlight recent and ongoing advances in the field of sarcoma biology, pre-clinical advances, new clinical trials and also the use of immune-oncology for treatment.
For exhibiting opportunities, please contact Kelly Hallberg at Kelly.Hallberg@NationwideChildrens.org.